- The 15th Chinese Society of Gynecologic Oncology National Conference and the 6th Southern China Ovarian Cancer Summit, March 10-13, 2016, Guangzhou
-
Soochit A, Zhang C, Liu J
- KMID: 2374252
- J Gynecol Oncol.
- 2016 Sep;27(5):e50.
- doi: 10.3802/jgo.2016.27.e50
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of stage I endometrial carcinoma patients treated with surgery alone: Siriraj Hospital experiences
-
Therasakvichya S, Kuljarusnont S, Petsuksiri J, Chaopotong P, Achariyapota V, Srichaikul P, Jaishuen A
- KMID: 2374250
- J Gynecol Oncol.
- 2016 Sep;27(5):e48.
- doi: 10.3802/jgo.2016.27.e48
OBJECTIVE: To evaluate the recurrence rates and patterns of failure in patients with stage I endometrial carcinoma after surgical staging without adjuvant therapy. METHODS: Medical records of 229 patients with stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
-
Martin JY, Urban RR, Liao JB, Goff BA
- KMID: 2374249
- J Gynecol Oncol.
- 2016 Sep;27(5):e47.
- doi: 10.3802/jgo.2016.27.e47
OBJECTIVE: Bevacizumab was recently approved by the US Food and Drug Administration for use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011
-
Patel SC, Frandsen J, Bhatia S, Gaffney D
- KMID: 2374247
- J Gynecol Oncol.
- 2016 Sep;27(5):e45.
- doi: 10.3802/jgo.2016.27.e45
OBJECTIVE: Evaluate the impact of radiotherapy on cause specific survival (CSS) and overall survival (OS) for stage (I-III) clear cell, mucinous, and endometriod ovarian cancer. METHODS: We analyzed incidence, survival, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
-
Lee J, Kim TH, Kim GE, Keum KC, Kim YB
- KMID: 2374254
- J Gynecol Oncol.
- 2016 Sep;27(5):e52.
- doi: 10.3802/jgo.2016.27.e52
OBJECTIVE: We aimed to assess the efficacy of neoadjuvant chemotherapy followed by surgery (NACT+S), and compared the clinical outcome with that of concurrent chemoradiotherapy (CCRT) in patients with International Federation... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
-
Lee SJ, Yang A, Wu TC, Hung CF
- KMID: 2374253
- J Gynecol Oncol.
- 2016 Sep;27(5):e51.
- doi: 10.3802/jgo.2016.27.e51
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of appropriate cone length to avoid positive cone margin in high grade cervical intraepithelial neoplasia
-
Kawano K, Tsuda N, Nishio S, Yonemoto K, Tasaki K, Tasaki R, Ushijima K
- KMID: 2374255
- J Gynecol Oncol.
- 2016 Sep;27(5):e54.
- doi: 10.3802/jgo.2016.27.e54
OBJECTIVE: To identify key factors for predicting positive cone margin and appropriate cone length. METHODS: We retrospectively reviewed the margin status of patients who received conization with high grade cervical intraepithelial... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
-
Paik ES, Kim TJ, Lee YY, Choi CH, Lee JW, Kim BG, Bae DS
- KMID: 2374248
- J Gynecol Oncol.
- 2016 Sep;27(5):e46.
- doi: 10.3802/jgo.2016.27.e46
OBJECTIVE: The aim of this study was to compare survival outcomes in two groups of patients with recurrent epithelial ovarian cancer (EOC) with initial recurrence detection by cancer antigen 125... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations between sexually transmitted infections, high-risk human papillomavirus infection, and abnormal cervical Pap smear results in OB/GYN outpatients
-
Kim HS, Kim TJ, Lee IH, Hong SR
- KMID: 2374251
- J Gynecol Oncol.
- 2016 Sep;27(5):e49.
- doi: 10.3802/jgo.2016.27.e49
OBJECTIVE: This study aimed to examine the meaning and usefulness of sexually transmitted infection (STI) test when caring for patients who have abnormal cervical cytology and/or positive high-risk human papillomavirus... -
- CITED
-
- Close
- SHARE
-
- Close
